Neuron (Cambridge, Mass.), 2010-07, Vol.67 (2), p.199-212
2010
Details
- Autor(en) / Beteiligte
- Titel
- Matrix Metalloproteinases Are Modifiers of Huntingtin Proteolysis and Toxicity in Huntington's Disease
- Ist Teil von
- Neuron (Cambridge, Mass.), 2010-07, Vol.67 (2), p.199-212
- Ort / Verlag
- United States: Elsevier Inc
- Erscheinungsjahr
- 2010
- Link zum Volltext
- Quelle
- EZB-FREE-00999 freely available EZB journals
- Beschreibungen/Notizen
- Proteolytic cleavage of huntingtin (Htt) is known to be a key event in the pathogenesis of Huntington's disease (HD). Our understanding of proteolytic processing of Htt has thus far focused on the protease families —caspases and calpains. Identifying critical proteases involved in Htt proteolysis and toxicity using an unbiased approach has not been reported. To accomplish this, we designed a high-throughput western blot-based screen to examine the generation of the smallest N-terminal polyglutamine-containing Htt fragment. We screened 514 siRNAs targeting the repertoire of human protease genes. This screen identified 11 proteases that, when inhibited, reduced Htt fragment accumulation. Three of these belonged to the matrix metalloproteinase (MMP) family. One family member, MMP-10, directly cleaves Htt and prevents cell death when knocked down in striatal Hdh 111Q/111Q cells. Correspondingly, MMPs are activated in HD mouse models, and loss of function of Drosophila homologs of MMPs suppresses Htt-induced neuronal dysfunction in vivo. [Display omitted] ► siRNA screens reveals therapeutic targets for Huntington's disease ► This screen identified 11 proteases that reduced Htt fragment accumulation ► Three of these belonged to the matrix metalloproteinase (MMP) family ► Loss of function of Fly homologs of MMPs Htt-induced neuronal dysfunction in vivo
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0896-6273eISSN: 1097-4199DOI: 10.1016/j.neuron.2010.06.021Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3098887
- Format
- –
- Schlagworte
- Animals, Apoptosis, Caspases - metabolism, Cell Death - drug effects, Cell Death - genetics, Cell Line, Transformed, Corpus Striatum - pathology, Disease Models, Animal, Drosophila, Enzymes, Gene Expression Regulation, Enzymologic - drug effects, Gene Expression Regulation, Enzymologic - genetics, Genomes, Humans, HUMDISEASE, Huntingtin Protein, Huntington Disease - genetics, Huntingtons disease, Insects, Matrix Metalloproteinases - classification, Matrix Metalloproteinases - genetics, Matrix Metalloproteinases - metabolism, Mice, Mice, Neurologic Mutants, MOLNEURO, Mutation - genetics, Nerve Tissue Proteins - drug effects, Nerve Tissue Proteins - genetics, Nerve Tissue Proteins - metabolism, Nerve Tissue Proteins - toxicity, Neurons - drug effects, Neurons - metabolism, Nuclear Proteins - drug effects, Nuclear Proteins - genetics, Nuclear Proteins - metabolism, Nuclear Proteins - toxicity, Peptides - genetics, Peptides - metabolism, Proteins, RNA, Small Interfering - pharmacology, RNA, Small Interfering - therapeutic use, Toxicity, Transfection - methods